Latest | F'cast | |
---|---|---|
Div Yield | 2.2% | 0.0% |
Div Cover | 1.3 | 2.6 |
Op Mrgn | 17.9% | 30.8% |
ROCE | 60.1% |
Latest | F'cast | |
---|---|---|
P/E | 35.1 | 16.4 |
PEG | 0.4 | 0.2 |
Pr/Revenue | 4.6 | 3.2 |
Pr/Book | 5.3 |
Latest | F'cast | |
---|---|---|
Revenue | 3.3% | -12.4% |
PBT | 175.8% | 79.4% |
EPS | 81.1% | 112.7% |
DPS | n/a | -32.5% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 24,384.00 | 1,548.00 | 103.00¢ | 93.2 | n/a | -39% | 280.00¢ | 2.9% |
31-Dec-20 | 26,617.00 | 3,916.00 | 244.00¢ | 37.9 | 0.3 | +137% | 280.00¢ | 3.0% |
31-Dec-21 | 37,417.00 | (265.00) | 8.00¢ | 1,369.4 | n/a | -97% | 287.00¢ | 2.6% |
31-Dec-22 | 44,351.00 | 2,501.00 | 212.00¢ | 66.8 | 0.0 | +2,550% | 290.00¢ | 2.0% |
31-Dec-23 | 45,811.00 | 6,899.00 | 384.00¢ | 34.8 | 0.4 | +81% | 290.00¢ | 2.2% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 50,652.78 | 15,622.29 | 648.16p | 16.5 | 0.1 | +113% | 246.98p | 0.0% |
31-Dec-25 | 54,503.57 | 17,859.33 | 735.10p | 14.5 | 1.1 | +13% | 258.56p | 0.0% |
31-Dec-26 | 57,326.46 | 19,166.55 | 801.86p | 13.3 | 1.5 | +9% | 264.15p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Ultomiris approved in the US for NMOSD | 25-Mar-2024 | 07:00 | RNS |
AstraZeneca to acquire Fusion | 19-Mar-2024 | 07:00 | RNS |
AstraZeneca to acquire Amolyt | 14-Mar-2024 | 07:00 | RNS |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
08-Mar-24 | Transfer From | Pascal Soriot | 0.000p | 105,238 | £0.00 |
20-Feb-24 | Transfer From | Pascal Soriot | 0.000p | 12,345 | £0.00 |
Currency | UK Pounds |
Share Price | 10,678.00p |
Change Today | -64.00p |
% Change | -0.60 % |
52 Week High | 12,294.00 |
52 Week Low | 9,501.00 |
Volume | 1,276,799 |
Shares Issued | 1,550.21m |
Market Cap | £165,531m |
RiskGrade | 123 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 7 |
Buy | 13 |
Neutral | 6 |
Sell | 0 |
Strong Sell | 2 |
Total | 28 |
Latest | Previous | |
---|---|---|
2nd Interim | 1st Interim | |
Ex-Div | 22-Feb-24 | 10-Aug-23 |
Paid | 25-Mar-24 | 11-Sep-23 |
Amount | 197.00¢ | 93.00¢ |
Time | Volume / Share Price |
16:58 | 10,298 @ 10,757.95p |
16:39 | 600 @ 10,678.00p |
16:37 | 1,835 @ 10,678.00p |
16:35 | 600 @ 10,678.00p |
16:35 | 400 @ 10,678.00p |
You are here: research